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A Novel Mouse Model for Neurotrophic Keratopathy:
Trigeminal Nerve Stereotactic Electrolysis through
the Brain
Giulio Ferrari,1,2,3 Sunil K. Chauhan,1,2 Hiroki Ueno,1 Nambi Nallasamy,1
Stefano Gandolfi,4 Lawrence Borges,5 and Reza Dana1,2
PURPOSE. To develop a mouse model of neurotrophic keratopa-
thy by approaching the trigeminal nerve through the brain and
to evaluate changes in corneal cell apoptosis and proliferation.
METHODS. Six- to 8-week-old male C57BL/6 mice underwent
trigeminal stereotactic electrolysis (TSE) to destroy the oph-
thalmic branch of the trigeminal nerve. Clinical follow-up using
biomicroscopy of the cornea was performed at days 2, 4, 5, and
7. To confirm the effectiveness of the procedure, we examined
the gross nerve pathology, blink reflex, and immunohisto-
chemistry of the corneal nerves. TUNEL-positive apoptotic and
Ki-67–positive proliferating corneal cells were evaluated to
detect changes from the contralateral normal eye.
RESULTS. TSE was confirmed by gross histology of the trigeminal
nerve and was considered effective if the corneal blink reflex
was completely abolished. TSE totally abolished the blink re-
flex in 70% of mice and significantly reduced it in the remain-
ing 30%. Animals with absent blink reflex were used for sub-
sequent experiments. In these mice, a progressive corneal
degeneration developed, with thinning of the corneal epithe-
lium and eventually perforation after 7 days. In all mice, 48
hours after TSE, corneal nerves were not recognizable histo-
logically. Seven days after TSE, an increase in cellular apoptosis
in all the corneal layers and a reduction in proliferation in basal
epithelial cells were detected consistently in all mice.
CONCLUSIONS. TSE was able, in most cases, to induce a disease
state that reflected clinical neurotrophic keratitis without dam-
aging the periocular structures. Moreover, corneal denervation
led to increased apoptosis and reduced proliferation of epithe-
lial cells, formally implicating intact nerve function in regulat-
ing epithelial survival and turnover. (Invest Ophthalmol Vis
Sci. 2011;52:2532–2539) DOI:10.1167/iovs.10-5688
The cornea is the most innervated tissue in the entire humanbody (400 times more than skin).1 It receives dense sen-
sory innervation from the trigeminal ganglion and, in some
species, modest autonomic innervation. The trigeminal nerve
divides into three main branches, one of which, the ophthal-
mic branch, provides corneal innervation. The organization of
corneal nerves, from the depth to the surface of the cornea, is
made up of penetrating stromal nerve bundles, subepithelial
plexus, sub-basal nerve plexus, and intraepithelial nerve termi-
nals.2 More than a dozen different neurotransmitters and neu-
ropeptides, whose functions are still incompletely understood,
are secreted by corneal nerves.3
Corneal nerves are lost because of many pathologic condi-
tions, such as ocular infection, topical anesthetic abuse, sur-
gery, diabetes, stroke, and dry eye syndrome,1,4–6 which affect
millions of people annually. When corneal nerves are severely
reduced, neurotrophic keratopathy (NK), a poorly treatable
disease, develops. This includes the development of persistent
epithelial defects and potentially stromal ulceration that may
progress to perforation. However, the exact mechanisms and
interactions between trigeminal nerves and corneal cells, in-
cluding stem cells, epithelial cells, and keratocytes, remain
unclear. It is known that nerve-secreted peptides influence
corneal cell proliferation in vitro,7 and corneal epithelial cell
mitosis has been shown to be altered in denervated rats.8,9
Apoptosis and cell proliferation play key roles in ocular
wound healing.10 Reduced cell proliferation and thinning have
been described in the denervated skin11; however, it is not
known whether enhanced apoptosis or simply reduced cell
proliferation is associated with NK. In addition, apoptosis and
proliferation have not been studied simultaneously in this con-
dition. This has significant clinical implications because it is a
well-known fact that NK patients have delayed healing and
often experience persistent epithelial defects12 and that even
minor injuries can seriously threaten ocular integrity.
To address these shortcomings in our current understand-
ing of these important pathophysiologic mechanisms, we have
developed, for the first time, a mouse model by removing
corneal nerves reproducibly using electrolysis of the ophthal-
mic branch of the trigeminal nerve with a stereotactic ap-
proach, trigeminal stereotactic electrolysis (TSE). This proce-
dure aims to destroy only the fibers providing corneal
innervation, leaving the rest of the trigeminus undamaged.
Other denervation models have been proposed in monkeys,13
rabbits,14–16 and rats.17,18 NK induction with a hot metal
probe through the roof of the mouth has been described in
mice; however, no report of death or success rate has been
provided, and no stereotactic technique was used.19 When the
same procedure was performed on rats, the authors reported a
success rate of 60%, and animals could be kept alive for only 3
to 6 days, which precludes long-term follow-up.9 Our method
represents an advancement of one of the most effective dener-
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vation procedures.20 In addition, this technique applies to the
mouse, which is the most widespread experimental mammal
used, and is available with the full array of research tools. The
procedure was followed by the development of progressive
degeneration of the corneal tissue, confirmed clinically by
biomicroscopy, functionally by examination of the blink reflex,
and histologically by the loss of corneal nerves and the degen-
eration of corneal tissues. Finally, we show histologic evidence
of a simultaneous increase in corneal cell apoptosis and a
reduction in basal epithelial cell proliferation.
METHODS
Animals
Five 6- to 8-week-old male C57BL/6 mice (Taconic Farms, German-
town, NY) were used in these experiments. The protocol was ap-
proved by the Schepens Eye Research Institute Animal Care and Use
Committee, and all animals were treated according to the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision Research.
Experimental Procedure
Animals were anesthetized with a ketamine (100 mg/mL)/xylazine (20
mg/mL)/acepromazine (15 mg/mL) mixture. The head of each animal
was shaved and disinfected with povidone iodide and ethanol. The
animal was then mounted in the stereotactic frame, with particular
attention paid to maintaining a sterile field in the surgical area, after
which a median incision was made on the skull. The bregma (the point
of conjunction of coronal and sagittal suture) was identified and cho-
sen as a point of reference. For preliminary anatomic reference, we
used a stereotaxic atlas.21 Experiments on mouse cadavers were per-
formed to calculate the exact stereotactic coordinates. The skull was
opened with a dental drill, a conductive unimodal electrode (FHC,
Bowdoin, ME) was lowered (depth, 0.63 cm) at three different loca-
tions (relative to bregma, 0.15 cm anterior and 0.08 cm lateral; 0.09
anterior and 0.10 lateral; 0.09 anterior and 0.12 lateral) on the oph-
thalmic trigeminal nerve, and a 2-mA current was passed for 15 sec-
onds.
The electrode was removed, and the skin was sutured. A lateral
tarsorrhaphy was performed to reduce the risk of infection. Finally,
antibiotic ointment (bacitracin-neomycin-polymyxin) was applied to
the sutural area and the treated eye. Buprenorphine (0.1 mg/kg body
weight every 8 to 12 hours for 72 hours) was injected subcutaneously.
The animals were then placed on a heated pad to help the recovery.
Corneal sensitivity using a cotton filament was recorded preoperatively
and postoperatively every 12 hours for 7 days comparing the blinking
of the treated (left) eye with that of the control (right) eye. All animals
were euthanatized by carbon dioxide overdose followed by cervical
dislocation. All the procedures were performed in the Schepens Eye
Research Institute Animal Facility in accordance with an approved
protocol.
Sham Procedure
The sham procedure was conducted by repeating the steps of the
experimental procedure (i.e., the electrode was lowered in the same
three locations) except that current was not passed through the elec-
trode. Antibiotic ointment was applied to the ipsilateral eye at the end
of the procedure.
Slit Lamp Digital Pictures
Digital pictures of the corneas were taken at the slit lamp at 2, 4, 5, and
7 days after the procedure to check for any change in corneal epithe-
lium or transparency. Particular attention was paid to the detection of
epithelial irregularities or corneal edema.
Gross Pathology and Histology
To confirm the site of the lesion, the ophthalmic branch of the
trigeminal nerve was exposed by careful dissection of the cerebral
hemispheres and removal of the surrounding tissues, and digital pic-
tures were taken.
The cornea was harvested and fixed in 4% paraformaldehyde,
permeabilized in 0.3% Triton X in PBS with 2% bovine serum albumin
for 2 hours, stained with anti–3 tubulin antibody (rabbit anti–beta 3
tubulin polyclonal antibody; Chemicon, Temecula, CA) overnight at
4°C, and then stained with a secondary conjugated antibody for 2
FIGURE 1. (A) Scheme of the TSE
procedure depicted in a coronal sec-
tion. (B) Gross pathology evidence of
trigeminal ablation induced by ste-
reotactic electrolysis. Representative
trigeminal nerve lesion induced on
left trigeminal nerve (arrow). Note
the normal contralateral nerve. ON,
optic nerve; TG, trigeminal ganglion;
V1, V2 (joined), and V3 are, respec-
tively, the ophthalmic, maxillary, and
mandibular branches of the trigemi-
nal nerve. (C) TSE induces damage in
the trigeminal nerve. Cross-sections
taken from the lesioned trigeminal
nerve (left) and contralateral normal
nerve (right) stained with Luxol fast
blue. Note the extensive disruption
and vacuolization of the treated tis-
sue. Original magnification, 400.
The postmortem examination was
performed 7 days after TSE.
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hours at room temperature (donkey anti-rabbit IgG FITC; Santa Cruz
Biotechnology, Santa Cruz, CA). Both primary and secondary antibod-
ies were diluted to 1:200. Corneal whole mounts were prepared using
a DAPI mounting medium (Vectashield mounting medium with DAPI;
Vector Laboratories, Burlingame, CA).
Trigeminal Nerve Histology
Trigeminal nerves were carefully dissected and fixed in 10% formalin
overnight. Samples were included in paraffin, and 5-m sections were
prepared and stained with Luxol fast blue, as described previously.22
TUNEL Staining
To measure apoptosis we used a specific kit (in situ cell death detec-
tion kit, TMR Red; Roche, Nutley, NJ). Eyes were enucleated and
prefixed in 4% paraformaldehyde, placed in OCT medium compound
(Tissue-Tek; Sakura Finetek, Torrance, CA), and stored at 80°C.
Eight-micrometer cryosections were prepared, postfixed in 4% para-
formaldehyde, and stained in accordance with the manufacturer’s
instructions. Eight corneas were examined (four denervated, four nor-
mal), and four different areas were sampled in each cornea, both in the
center and in the periphery. Images were taken at 200magnification.
TUNELCD45 cells were identified by double staining for TUNEL
and CD45 marker. Briefly, eyes were enucleated and prefixed in 4%
paraformaldehyde, and the cornea was removed and stained for TUNEL
as described. Corneas were then stained with CD45 monoclonal con-
jugated antibody (AlexaFluor 488 anti-mouse CD45 antibody; BioLeg-
end, San Diego, CA) and mounted. Images were taken at 400 mag-
nification.
Ki-67 Staining
For measuring proliferation, enucleated globes were placed in OCT
compound, and sagittal sections measuring 8 m were cut with a
cryostat and placed on glass slides. Slides were fixed in acetone, rinsed
in PBS, and blocked with 1% bovine serum albumin. Sections were
then processed for immunohistochemical and morphologic evalua-
tions. Actively proliferating cells were identified by immunofluores-
cence using a FITC-conjugated mouse monoclonal antibody against the
Ki-67 protein (Novocastra Laboraties, Newcastle, UK), a cell prolifera-
tion marker expressed during active phases of the cell cycle.23 The
FIGURE 2. Representative slit lamp
photographs demonstrating the devel-
opment of neurotrophic keratopathy
at different time points after unilateral
central trigeminal electrocoagulation
compared with the contralateral side.
(A, C, E, G) Normal contralateral eye.
(B, D, F, H) Denervated eye. Func-
tional testing of blink reflex was per-
formed by touching the cornea with a
cotton thread. Note the absence of
blink reflex (arrow). (B). Starting 48
hours after the procedure, the devel-
opment of punctate keratopathy was
observed (B). This extended progres-
sively (D, F) to form a confluent area
of severe epithelial defect (H). The
contralateral cornea retained transpar-
ency (A, C, E, G) and a normal blink
reflex.
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antibody was diluted 1:100 and placed on the sections, and cryosec-
tions were prepared. We examined eight corneas (four denervated and
four normal) and sampled four areas in each cornea centrally. All digital
pictures were taken under a fluorescence microscope (E800; Nikon,
Melville, NY) with a 600 magnification.
Epithelial Thickness
To study the effect of the procedure on epithelial thickness, whole
globes were removed and fixed in OCT cryoprotectant medium and
stored in 80°C. Eight-micrometer cryosections were cut. We exam-
ined 10 eyes (five denervated and five normal) in four different areas in
the central cornea. Corneal epithelial thickness was determined using
automated image analysis software (MatLab; The MathWorks Inc.,
Natick, MA). Epithelium was segmented from microscopic corneal
images using morphologic techniques. Thickness measurements were
determined by averaging more than three sampled locations per image.
Blink Reflex Evaluation
The blink reflex was tested with a cotton thread, both in the central
and the peripheral cornea, immediately after animal recovery from
FIGURE 3. Representative histologic
photomicrographs of corneal nerves
immunostained with anti–3-tubulin
FITC-conjugated antibody showing
peripheral sub-basal nerve plexus
(left), paracentral sub-basal nerve
plexus (middle), and stromal nerves
(right) in a normal eye, and 24 hours
and 48 hours after trigeminal dener-
vation. Note the development of
marked nerve degeneration after 24
hours, where nerves appear faint and
interrupted (small arrows). After 48
hours, no clear nerve structures
could be detected. Original magnifi-
cation, 400.
FIGURE 4. Reduced epithelial thick-
ness after trigeminal denervation. (A)
Representative histologic photomicro-
graphs of hematoxylin and eosin–
stained globe sections obtained from
the central cornea of the untreated eye
and 5 days after performing trigeminal
stereotactic electrolysis. Note the re-
duction of thickness of epithelium. In
the treated eye, only a very thin epi-
thelium has remained. Original magni-
fication, 600. (B) Quantification of
corneal epithelial thickness. Note the
significantly reduced thickness in the
denervated eye (*P  0.001). Bars in-
dicate SE.
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anesthesia and then every 12 hours until the animals were euthana-
tized. Unanesthetized mice were tested for the blink reflex by touching
the center and the periphery of the cornea with a sterile filament of
cotton, under a dissecting microscope (magnification 10), to avoid
touching the whiskers and eyelashes, as previously described.24 Only
animals showing absence of reflex at all times were used for the
experiments.
RESULTS
Electrocoagulation of the Ophthalmic Branch of
the Trigeminal Nerve
A schematic diagram showing a coronal view of the TSE pro-
cedure is provided in Figure 1A. After TSE, gross pathology of
the trigeminal nerve revealed a lesion in the left ophthalmic
branch (Fig. 1B). A characteristic burn induced by the electro-
coagulation could be seen at the site of the electrode penetra-
tion (the ophthalmic branch). On histochemical analysis, the
treated trigeminal nerve tissue showed extensive disruption
and vacuolization compared with the untreated, contralateral
nerve (Fig. 1C).
The maxillary and mandibular branches appeared intact.
This was further confirmed as recovered animals responded
to the touch of the respective innervated areas. The optic
nerves were intact. No apparent hemorrhage or lesion was
evident in the ganglion, hemispheres, or outside the tar-
geted area. The sham procedure was not associated with any
changes.
In Vivo Evaluation of Corneal Integrity and
Blinking Reflex
Biomicroscopy of the cornea showed a progressive develop-
ment of keratopathy; this started as punctate keratopathy 48
hours after the procedure, which progressively coalesced to
diffuse epitheliopathy 7 days later (Fig. 2). When the sham
procedure was performed (i.e., electrode was lowered but no
current passed), the cornea remained normal and the blink
reflex was maintained at all time points. The epithelium im-
aged at the slit lamp showed areas of disruption 24 hours after
the procedure, which increased after 48 hours (Fig. 2). The
blink reflex, tested with a cotton thread, was found to be
totally absent in 70% of animals treated and significantly re-
duced in the remaining 30% (Fig. 2B). Only animals with totally
absent reflex both in the central and the peripheral cornea at
all time points were used in this study.
Ex Vivo Evaluation of Corneal Innervation
In nontreated contralateral eyes, the subbasal nerve plexus and
thick stromal trunks were normally present. In the TSE group,
24 hours after denervation, the subbasal nerve plexus lost its
characteristic branching pattern. Moreover, the stromal nerves
in the TSE group appeared faint and disrupted at various
points. At 48 hours, no clear nerve structure could be detected
either in the subbasal nerve plexus or the stroma (Fig. 3).
Thickness of Corneal Epithelial Cell Layer
Globe cross-sections stained with hematoxylin-eosin 5 days
after the procedure were prepared and showed a reduction in
FIGURE 5. Increased corneal apopto-
sis after trigeminal denervation. (A) Ap-
optosis in normal and denervated cor-
neal cross-sections detected by TUNEL
technique. Nuclei are stainedwithDAPI.
Normal cornea: note the multilayered
epithelium and the scarce number of
apoptotic cells, which are mainly lo-
cated in the superficial epithelium. De-
nervated cornea: note the extremely
thin epithelium, which is reduced to a
few layers, and the numerous apoptotic
cells, which are located throughout
the cornea. (B) Quantification of apop-
tosing cells in the epithelium and
stroma of the central and peripheral
cornea. Note the significantly in-
creased apoptosis in the denervated
cornea (*P  0.001). Number of
TUNEL cells per microscopic field
was counted at 200 magnification.
Bars indicate SE. (C) Representative
micrographs of corneal whole mounts
showing phenotypes of apoptotic cells
in the stroma. Increased keratocyte
and inflammatory cell (CD45) apop-
tosis after denervation. Note the infil-
tration of CD45 cells after TSE and
the presence of TUNELCD45 cells
suggesting that keratocytes are also un-
dergoing apoptosis. Original magnifi-
cation, 400.
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the epithelial thickness (mean, 35%) (Fig. 4A). The epithelial
thickness was significantly reduced (P  0.001) in the dener-
vated eye compared with the normal contralateral eye (Fig.
4B). In addition, we found infiltration of inflammatory cells that
was located primarily in the anterior stroma, in the denervated
corneas.
Apoptosis of Corneal Cells
Immunohistochemistry for TUNEL apoptotic cells was per-
formed 7 days after denervation. TUNEL cells in the epithe-
lium, stroma, and endothelium of the denervated eye were
identified under the microscope and counted. Two areas were
considered: central and peripheral (limbal) cornea. In the nor-
mal eye, few epithelial cells were TUNEL, and they were
located primarily in the outer superficial layers (Fig. 5A). In the
diseased eye, an increased number of TUNEL cells were
detected diffusely scattered in the epithelium, stroma, and
even the endothelium. More specifically, we observed a 70%
increase in apoptotic cells in both the central and the periph-
eral epithelium and 86% and 76% increases in the central and
peripheral stroma, respectively, compared with normal eyes
(Fig. 5B). The difference in the TUNEL cell counts between
normal and denervated eyes was statistically significant (P 
0.001). Further, to characterize the phenotype of these cells,
we performed corneal whole mount staining for CD45 and
TUNEL. On comparison between denervated and nondener-
vated corneal stromas, we noticed significant increases in the
numbers of both live (TUNEL) and dead (TUNEL) CD45
cells in denervated eyes. In addition, we found an increase in
the CD45 TUNEL cells in denervated eyes, suggesting in-
creased apoptosis of keratocytes (Fig. 5C).
Proliferation of Basal Epithelial Cells
Immunohistochemistry for Ki-67 performed on globe cross-
sections 7 days after denervation showed a reduction of Ki-67
cells in the basal epithelial layer of the denervated eyes, though
they were normally present in the normal contralateral eyes
(Fig. 6A). When we compared the number of Ki-67 cells in
normal and denervated eyes, we found a reduction of 90% in
the latter (P  0.001) (Fig. 6B).
DISCUSSION
The prevalence of NK is unknown, but it is probably underes-
timated given that reduction in corneal sensation is a common
clinical observation in most severe chronic corneal diseases. In
spite of significant efforts to unravel the pathophysiology of
NK, it is not yet clear why NK patients have delayed healing
times because they often present with persistent epithelial
defects, and even minor injuries can seriously threaten ocular
integrity.12 Reduced mitosis of the epithelial cells has been
demonstrated,8,9 but no report about the role of apoptosis in
NK has been produced, nor has its coexistence with prolifer-
ation reduction been evaluated. To test whether denervation
influences cell proliferation or apoptosis, we developed the
TSE, a procedure aimed at inducing NK in mice without sur-
gical or experimental manipulation of the globe or periocular
tissues. In addition, to better understand NK pathophysiology,
a reproducible murine model would be helpful to test new
therapies. We also propose this method could be used to study
the effect of trigeminal denervation in ocular tissues different
from the cornea (such as the anterior chamber, retina, and
choroid) because little is known about the physiologic rele-
vance of trigeminal innervation to the eye.
In this study, we demonstrated a reproducible surgical ap-
proach, TSE, that induces corneal nerve disruption and is
followed by the development of an epithelial and stromal
disease highly resemblant of human NK. We demonstrated the
site of the lesion in the trigeminal nerve and its peripheral
effect on corneal nerve degeneration. Our approach requires
30 minutes and leaves the eye and orbital structures un-
touched, and it does not require the application of any chem-
ical substance to the eye or periocular structures that could
potentially introduce confounding factors. Attempts to remove
corneal nerves with toxins (such as capsaicin25,26 or other
neurotoxins27,28) or to surgically denervate by axotomy in the
orbital cavity can cause significant perturbation of the microen-
vironment and could induce inflammation or cell apoptosis as
a result of trauma itself. For example, capsaicin injection aspe-
cifically affects all sensory neurons in the body, and it has been
shown to change the level of brain derived neurotrophic factor
in the dorsal root ganglions.
Several neurotrophic keratopathy models have been de-
scribed in rats,17,18,20 rabbits,14–16 and monkeys.13 However,
to our knowledge, a reproducible mouse model that could
circumvent these issues (e.g., of inducing significant anatomic
disruption around the eye or inducing chemical injury to the
ocular surface, as with ethanol) approaching the trigeminal
FIGURE 6. Reduced basal epithelial cell proliferation after trigeminal
denervation. (A) Ki-67 detection of proliferating basal epithelial cell in
cornea cross-sections. Note the numerous Ki-67 cells in the normal
corneal basal epithelium. After trigeminal denervation, the number of
Ki-67 cells is significantly reduced, and only a few faintly stained basal
cells can be detected (arrows). (B) Quantification of Ki-67 cells in
normal and denervated corneas. Note the reduction in proliferating
cells after denervation (*P  0.001). Number of Ki-67 cells per
microscopic field was counted at 600magnification. Bars indicate SE.
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nerve from the brain has not yet been described. We believe
this can represent a significant improvement, given the low
cost and the wide array of murine reagents for the study of
pathophysiologic mechanisms and the wide availability of
transgenic and knockout models.
Tissue homeostasis in normal physiology is controlled by a
tight regulation of apoptosis and proliferation, and it is inter-
esting to speculate that the balance between these two mech-
anisms is perturbed in neurotrophic keratopathy. Apoptosis,
also known as programmed cell death, plays a major role in
most mechanisms of regulation of differentiation and wound
healing.10 Denervation has a dramatic effect on the apoptosis
of myocytes29 and Leydig cells.30 In the cornea, apoptosis has
been shown to occur after infection,31 surgery,32 or topical
drug application.33 However, no report has described the im-
pact of denervation on corneal apoptosis. Apoptosis has been
related to corneal opacity34 and punctate keratopathy,35 which
we found in the TSE-treated eyes. In our study, we found
apoptosis increased after TSE. Interestingly, although in normal
eyes apoptosis was found at a background level primarily in the
superficial epithelium, consistent with normal tissue turnover,
we noted that 7 days after denervation, apoptosis was also
extensively detected in keratocytes and even endothelial cells,
suggesting a trophism support of nerves beyond just the epi-
thelium. Interestingly, apoptotic cells were found diffusely
scattered in all corneal layers, whereas the majority of inflam-
matory cells were located in the anterior stroma, hence sug-
gesting that resident corneal cells were undergoing apoptosis.
To better assess the phenotype of corneal cells undergoing apop-
tosis, we performed double staining for TUNEL and CD45 (as a
marker of inflammatory cells) and found that TUNELCD45
cells, which could presumably be considered resident kerato-
cytes, were increased after denervation.
Various neuropeptides found in the cornea, such as sub-
stance P (SP),36 calcitonin gene-related peptide (CGRP),37 and
nerve growth factor (NGF),38 have antiapoptotic properties,
and their reduction or disappearance after denervation could
explain our findings. Corneal nerve-secreted peptides such as
SP,39 NGF,40,41 and glial-derived neurotrophic factor,41 have
also been shown to support the proliferation of corneal cells.
It has also been shown that corneal denervation induces a
reduction of epithelial cell mitosis in rats,8,9 but no information
is available in mice.
We evaluated actively proliferating corneal cells by staining
for Ki-67 protein, a cell proliferation marker expressed during
the active phases of the cell cycle (G1, S, G2, and mitosis) but
absent from resting cells (G0).42 Ki-67 has been used to identify
proliferating corneal epithelial cells.43 We found Ki-67 expres-
sion reduced after TSE. We also detected reduced epithelial
thicknesses in the central cornea.43,44 Interestingly, this is
similar to what has been reported for the denervated epidermis
in which keratinocyte proliferation was also reduced.11 The
epidermis shares anatomic similarity with the cornea because it
is also surface ectoderm-derived; however, it is a keratinized
epithelium. Our findings support the general theory of a spe-
cific neurotrophic effect on ectodermal tissues, which has
been proposed by various authors.46,47
The penetration of the electrode through the brain to reach
the trigeminal nerve can be complicated by meningoencepha-
litis23; however, we did not notice neurologic or autoptic signs
of development of brain infections in our animals. This could
be partly due to the fact that we followed a rigorous aseptic
technique. We do not know to what extent other factors (i.e.,
inflammation) participated in the development of NK; how-
ever, this will be the subject of further studies. In addition, the
trajectory of the electrode through the brain tissue could the-
oretically alter the release of neuropeptides in the cornea.
However, when we performed a sham procedure (i.e., same
procedure with lowering of the electrode to the trigeminal
nerve without passing current), the ipsilateral eye remained
normal. TSE was effective in totally abolishing the blink reflex
in 70% of cases, and the animal survival rate free of neurologic
complications such as paralysis was 90%. Because it has been
shown that in some cases the cornea receives innervation from
the maxillary branch of the trigeminal nerve,18,47,48 we hy-
pothesize that our specific lesion of the ophthalmic branch
may spare these fibers in some animals, thereby allowing re-
tention of some sensation in a minority of cases.
The development and clinical evolution of NK after TSE was
rapid (7 days) compared to what has been shown in rats17,18,20
and what is observed in humans, possibly because of various
reasons. First, mice are smaller than rats, and it is possible that
the time required for nerve degeneration is shorter given the
shorter fibers. Second, we included in our study only animals
with complete corneal anesthesia, defined by the complete
absence of corneal reflex, which presumably would experi-
ence the most severe form of NK. Third, human patients often
undergo some sort of therapy, which slows down the course of
the disease, and reduced sensation is more common than
complete corneal anesthesia.
In conclusion, our findings support the importance of cor-
neal nerves on the two main mechanisms of tissue homeosta-
sis: apoptosis and cell proliferation. We emphasize that the
adoption of our animal model could provide a useful tool in
dissecting the role of nerves on various adult and stem cell
populations in the cornea and, more widely, could be a para-
digm of nerve-tissue interactions in health and disease, ulti-
mately facilitating the development of new therapies.
Acknowledgments
The authors thank Jessica Lanzim for help with the animal care and
Don Pottle and Qiang Zhang for the excellent technical assistance.
References
1. Rozsa AJ, Beuerman RW. Density and organization of free nerve
endings in the corneal epithelium of the rabbit. Pain. 1982;14:
105–120.
2. Al-Aqaba M, Fares U, Suleman H, Lowe J, Dua HS. Architecture and
distribution of human corneal nerves. Br J Ophthalmol. 2010;94:
784–789.
3. Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: struc-
ture, contents and function. Exp Eye Res. 2003;76:521–542.
4. Epstein DL, Paton D. Keratitis from misuse of corneal anesthetics.
N Engl J Med. 1968;279:396–399.
5. Benitez del Castillo JM, Wasfy MA, Fernandez C, Garcia-Sanchez J.
An in vivo confocal masked study on corneal epithelium and
subbasal nerves in patients with dry eye. Invest Ophthalmol Vis
Sci. 2004;45:3030–3035.
6. Kaufman SC. Anterior segment complications of herpes zoster
ophthalmicus. Ophthalmology. 2008;115:S24–S32.
7. Garcia-Hirschfeld J, Lopez-Briones LG, Belmonte C. Neurotrophic
influences on corneal epithelial cells. Exp Eye Res. 1994;59:597–
605.
8. Sigelman S, Dohlman CH, Friedenwald JS. Mitotic and wound
healing activities in the rat corneal epithelium: influence of various
hormones and endocrine glands. Arch Ophthalmol. 1954;52:751–
757.
9. Sigelman S, Friedenwald JS. Mitotic and wound-healing activities of
the corneal epithelium: effect of sensory denervation. Arch Oph-
thalmol. 1954;52:46–57.
10. Salomao MQ, Wilson SE. Corneal molecular and cellular biology
update for the refractive surgeon. J Refract Surg. 2009;25:459–
466.
11. Huang IT, Lin WM, Shun CT, Hsieh ST. Influence of cutaneous
nerves on keratinocyte proliferation and epidermal thickness in
mice. Neuroscience. 1999;94:965–973.
2538 Ferrari et al. IOVS, April 2011, Vol. 52, No. 5
12. Jeng BH, Dupps WJ Jr. Autologous Serum 50% eyedrops in the
treatment of persistent corneal epithelial defects. Cornea. 2009;
28:1104–1108.
13. Oduntan O, Ruskell G. The source of sensory fibres of the inferior
conjunctiva of monkeys. Graefe’s Arch Clin Exp Ophthalmol.
1992;230:258–263.
14. Schimmelpfennig B, Beuerman R. A technique for controlled sen-
sory denervation of the rabbit cornea. Graefe’s Arch Clin Exp
Ophthalmol. 1982;218:287–293.
15. Schimmelpfennig B, Beuerman RW. Sensory denervation of the
rabbit cornea affects epithelial properties. Exp Neurol. 1980;69:
196–201.
16. Gilbard JP, Rossi SR. Tear film and ocular surface changes in a
rabbit model of neurotrophic keratitis. Ophthalmology. 1990;97:
308–312.
17. Wong EK, Kinyamu RD, Graff JM, et al. A rat model of radiofre-
quency ablation of trigeminal innervation via a ventral approach
with stereotaxic surgery. Exp Eye Res. 2004;79:297–303.
18. Tervo T, Joo F, Huikuri KT, Toth I, Palkama A. Fine structure of
sensory nerves in the rat cornea: an experimental nerve degener-
ation study. Pain. 1979;6:57–70.
19. Zander E, Weddell G. Reaction of corneal nerve fibers to injury.
Br J Ophthalmol. 1951;35:61–88.
20. Nagano T, Nakamura M, Nakata K, et al. Effects of substance P and
IGF-1 in corneal epithelial barrier function and wound healing in a
rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci.
2003;44:3810–3815.
21. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordi-
nates. 2nd ed. San Diego: Academic Press; 2001.
22. Saadoun S, Tait MJ, Reza A, Davies DC, Bell BA, Verkman AS,
Papadopoulos MC. AQP4 gene deletion in mice does not alter
blood-brain barrier integrity or brain morphology. Neuroscience.
2009;7:161:764–772.
23. Brown DC, Gatter KC. Ki67 protein: the immaculate deception?
Histopathology. 2002;40:2–11.
24. Tullo AB, Shimeld C, Blyth WA, Hill TJ, Easty DL. Ocular infection
with herpes simplex virus in nonimmune and immune mice. Arch
Ophthalmol. 1983;101:961–964.
25. Keen P, Tullo AB, Blyth WA, Hill TJ. Substance P in the mouse
cornea: effects of chemical and surgical denervation. Neurosci
Lett. 1982;29:231–235.
26. Hiura A, Nakagawa H. Capsaicin-resistant, nonspecific acetylcho-
linesterase (NsAchE) reactive nerve fibers in the rat cornea: a
quantitative and developmental study. Okajimas Folia Anatomica
Japonica. 2004;81:75–84.
27. Gallar J, Garcia de la Rubia P, Gonzalez GG, Belmonte C. Irritation
of the anterior segment of the eye by ultraviolet radiation: influ-
ence of nerve blockade and calcium antagonists. Curr Eye Res.
1995;14:827–835.
28. Olurin O, Osuntokun O. Complications of retrobulbar alcohol
injections. Ann Ophthalmol. 1978;10:474–476.
29. Siu PM. Muscle apoptotic response to denervation, disuse, and
aging. Med Sci Sports Exercise; 2009;41:1876–1886.
30. Gong YG, Wang YQ, Gu M, Feng MM, Zhang W, Ge RS. Deprival
of testicular innervation induces apoptosis of Leydig cells via
caspase-8-dependent signaling: a novel survival pathway revealed.
Biochem Biophys Res Commun. 2009;382:165–170.
31. Zhou Z, Bar rett RP, McClellan SA, et al. Substance P delays
apoptosis, enhancing keratitis after Pseudomonas aeruginosa in-
fection. Invest Ophthalmol Vis Sci. 2008;49:4458–4467.
32. Brignole F, Auzerie O, Baudouin C. Apoptosis and the ocular
surface. J Francais d’ Ophtalmol. 2003;26:299–306.
33. Song JS, Kim JH, Yang M, Sul D, Kim HM. Mitomycin-C concen-
tration in cornea and aqueous humor and apoptosis in the stroma
after topical mitomycin-C application: effects of mitomycin-C ap-
plication time and concentration. Cornea. 2007;26:461–467.
34. Van Meter WS. Central corneal opacification resulting from recent
chemotherapy in corneal donors. Trans Am Ophthalmol Soc.
2007;105:207–212.
35. Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K.
Autologous serum eye drops for the treatment of dry eye diseases.
Cornea. 2008;27(suppl 1):S25–S30.
36. Huang B, Fu H, Yang M, Fang F, Kuang F, Xu F. Neuropeptide
substance P attenuates hyperoxia-induced oxidative stress injury in
type II alveolar epithelial cells via suppressing the activation of
JNK pathway. Lung. 2009;187:421–426.
37. Chan JJ, Farmer PJ, Southwell BR, Sourial M, Hutson JM. Calcitonin
gene-related peptide is a survival factor, inhibiting apoptosis in neo-
natal rat gubernaculum in vitro. J Pediatr Surg. 2009;44:1497–1501.
38. Kishi S, Shimoke K, Nakatani Y, et al. Nerve growth factor attenuates
2-deoxy-d-glucose-triggered endoplasmic reticulum stress-mediated apo-
ptosis via enhanced expression of GRP78.Neurosci Res. 2010;66:14–21.
39. Reid TW, Murphy CJ, Iwahashi CK, Foster BA, Mannis MJ. Stimu-
lation of epithelial cell growth by the neuropeptide substance P. J
Cell Biochem. 1993;52:476–485.
40. Kruse FE, Tseng SC. Growth factors modulate clonal growth and
differentiation of cultured rabbit limbal and corneal epithelium.
Invest Ophthalmol Vis Sci. 1993;34:1963–1976.
41. You L, Kruse FE, Volcker HE. Neurotrophic factors in the human
cornea. Invest Ophthalmol Vis Sci. 2000;41:692–702.
42. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the
unknown. J Cell Physiol. 2000;182:311–322.
43. Fabiani C, Barabino S, Rashid S, Dana MR. Corneal epithelial pro-
liferation and thickness in a mouse model of dry eye. Exp Eye Res.
2009;89:166–171.
44. Henriksson JT, McDermott AM, Bergmanson JP. Dimensions and
morphology of the cornea in three strains of mice. Invest Oph-
thalmol Vis Sci. 2009;50:3648–3654.
45. Albers KM, Davis BM. The skin as a neurotrophic organ. Neuro-
scientist. 2007;13:371–382.
46. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M.
Neuronal control of skin function: the skin as a neuroimmunoen-
docrine organ. Physiol Rev. 2006;86:1309–1379.
47. Ruskell GL. Ocular fibres of the maxillary nerve in monkeys. J
Anat. 1974;118:195–203.
48. Marfurt CF, Kingsley RE, Echtenkamp SE. Sensory and sympathetic
innervation of the mammalian cornea: a retrograde tracing study.
Invest Ophthalmol Vis Sci. 1989;30:461–472.
IOVS, April 2011, Vol. 52, No. 5 A Novel Animal Model of Neurotrophic Keratopathy 2539
